WILDEHALL_BLOODSTOCK_LIMI - Accounts


Company Registration No. 08721748 (England and Wales)
WILDEHALL BLOODSTOCK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2021
PAGES FOR FILING WITH REGISTRAR
WILDEHALL BLOODSTOCK LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
WILDEHALL BLOODSTOCK LIMITED
BALANCE SHEET
AS AT
31 MAY 2021
31 May 2021
- 1 -
2021
2020
Notes
£
£
£
£
Current assets
Debtors
3
1,612
1,612
Cash at bank and in hand
575
575
2,187
2,187
Creditors: amounts falling due within one year
4
(247,530)
(247,530)
Net current liabilities
(245,343)
(245,343)
Capital and reserves
Called up share capital
2
2
Profit and loss reserves
(245,345)
(245,345)
Total equity
(245,343)
(245,343)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 May 2021 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for:

  •     ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

  •     preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 17 February 2022 and are signed on its behalf by:
Mr P E Wildes
Director
Company Registration No. 08721748
WILDEHALL BLOODSTOCK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2021
- 2 -
1
Accounting policies
Company information

Wildehall Bloodstock Limited is a private company limited by shares incorporated in England and Wales. The registered office is Wildes House, Worksop Road, Clowne, Chesterfield, S43 4TD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

2
Employees

The average monthly number of persons employed by the company during the year was:

2021
2020
Number
Number
Total
-
0
-
0
3
Debtors
2021
2020
Amounts falling due within one year:
£
£
Other debtors
1,612
1,612
4
Creditors: amounts falling due within one year
2021
2020
£
£
Other creditors
247,530
247,530
2021-05-312020-06-01true17 February 2022CCH SoftwareCCH Accounts Production 2021.300No description of principal activityMr P E WildesMr Anthony HallMr M A Wildes087217482020-06-012021-05-31087217482021-05-31087217482020-05-3108721748core:CurrentFinancialInstrumentscore:WithinOneYear2021-05-3108721748core:CurrentFinancialInstrumentscore:WithinOneYear2020-05-3108721748core:ShareCapital2021-05-3108721748core:ShareCapital2020-05-3108721748core:RetainedEarningsAccumulatedLosses2021-05-3108721748core:RetainedEarningsAccumulatedLosses2020-05-3108721748bus:Director12020-06-012021-05-31087217482019-06-012020-05-3108721748core:WithinOneYear2021-05-3108721748core:WithinOneYear2020-05-3108721748core:CurrentFinancialInstruments2021-05-3108721748core:CurrentFinancialInstruments2020-05-3108721748bus:EntityNoLongerTradingButTradedInPast2020-06-012021-05-3108721748bus:PrivateLimitedCompanyLtd2020-06-012021-05-3108721748bus:SmallCompaniesRegimeForAccounts2020-06-012021-05-3108721748bus:FRS1022020-06-012021-05-3108721748bus:AuditExemptWithAccountantsReport2020-06-012021-05-3108721748bus:Director22020-06-012021-05-3108721748bus:CompanySecretary12020-06-012021-05-3108721748bus:FullAccounts2020-06-012021-05-31xbrli:purexbrli:sharesiso4217:GBP